Tirzepatide is a peptide used in the treatment of Type 2 Diabetes and Obesity. It is a dual GIP (Glucose-dependent insulinotropic peptide) and GLP-1 (glucagon-like peptide-1) receptor against that aids in weight loss and blood sugar management. It is administered as a once-weekly injectable medication.

​

Tirzepatide is the active ingredient in Mounjaro® and Zepbound™

​

Tirzepatide vs Semaglutide:

​

Greater weight loss with tirzepatide as seen in clinical trials:

21.1% average weight reduction with tirzepatide

10-15% average weight reduction with semaglutide

​

Less side effects reported with tirzepatide 

​

Less risk of hypoglycemia with tirzepatide

​

How it works:

​

Targets areas in the brain that suppresses appetite and reduces cravings 

​

Delays digestion and stomach emptying → leaving you feeling fuller for a longer period of time, more satisfied with smaller meals and smaller portions → leading to weight loss

​

With it's combined positive benefits to blood pressure, cholesterol, and blood sugar, Tirzepatide positively impacts your cardiovascular health and decreases your risk for heart disease.